Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
600 participants
INTERVENTIONAL
2007-02-28
2007-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating the Effect of Mucinex® 1200 mg on Mucociliary and Cough Clearance From the Human Lung
NCT00902707
Clinical Trial to Assess the Efficacy and Safety of MUCOLASE Tablet(Streptokinase • Streptodornase)
NCT04252963
A Study to Explore if Long-term Use of Mucinex Can Help With Symptoms in Patients With Stable Chronic Bronchitis.
NCT05843669
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen
NCT01644877
The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2
NCT04313023
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mucinex D (600 mg guaifenesin and 60 mg pseudoephedrine HCl extended-release bi-layer tablets)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Genders Eligible for Study: Both
* Adult patients presenting at the physician's office with symptoms diagnostic for acute respiratory infection, such as bronchitis or rhinosinusitis; with a clinical diagnosis of acute respiratory infection, meeting the physician's usual diagnostic criteria in practice for prescription of oral antibiotics.
* The investigator will evaluate patients on a total of seven criteria for inclusion.
Exclusion Criteria
* The Investigator will evaluate patients on twelve additional criteria for exclusion.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Adams Respiratory Therapeutics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Adams RT
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Helmut Albrecht, M.D.
Role: STUDY_CHAIR
Adams Respiratory Therapeutics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alabama Clinical Therapuetics, LLC, 52 Medical Park East Drive, Suite 214
Birmingham, Alabama, United States
MedCenter, 6651 Madison Ave.
Carmichael, California, United States
Torrance Clinical Research, 3640 Lomita Blfd #205
Torrance, California, United States
Clinicos, LLC
Colorado Springs, Colorado, United States
Longmont Clinic, P.C., 1925 W. Mountain View Ave.
Longmont, Colorado, United States
Front Range Clinical Research
Wheat Ridge, Colorado, United States
Dawsonville Family Medicine Clinical Trials, 5983 Hwy, 53E. Ste 175
Dawsonville, Georgia, United States
Koch Family Medicine, 81A E. Queenwood Rd.
Morton, Illinois, United States
Welborn Clinic Gateway, 4233 Gateway Blvd
Newburgh, Indiana, United States
Sterling Research Group, Ltd., 650 Sprucewood Lane
Erlanger, Kentucky, United States
Columbia Medical Practice, 3450 Knoll Dr. North #200C
Columbia, Maryland, United States
Clinical Associates, 750 Main St. #201
Reisterstown, Maryland, United States
Milford Emergency Associates, Inc., 14 Asylum St.
Milford, Massachusetts, United States
Michigan Institute of Medicine, 38525 Eight Mile Rd.
Livonia, Michigan, United States
Central Nebraska Medical Clinic, PC, 145 Memorial Drive
Broken Bow, Nebraska, United States
Immedicenter, 557 Broad St.
Bloomfield, New Jersey, United States
Central New York Clinical Research, RT 92, The Market Place
Manlius, New York, United States
North Carolina Clinical Research, 4301 Lake Boone Trail, Ste 309-A
Raleigh, North Carolina, United States
DayStar Clinical Research, Inc., 880 Mull Ave., Suite 100
Akron, Ohio, United States
DataPharm, Inc., 6715 Tippecanoe Rd., Bldg E (LL)
Canfield, Ohio, United States
Parsons Avenue Medical Clinic, 1493 Parsons Avenue
Columbus, Ohio, United States
Blair Medical Associates, Inc., Station Medical Center, 1414 Ninth Ave.
Altoona, Pennsylvania, United States
Harleysville Medical Associates, 176 Main Street
Harleysville, Pennsylvania, United States
Lederach Family Medicine, PC, 658 Harleysville Pike, Suite 120
Harleysville, Pennsylvania, United States
Greentree Medical Associates, 651 Holiday Drive, Foster Plaza Bldg #5
Pittsburgh, Pennsylvania, United States
MetaClin Research, Inc., 6012 West William Cannon Drive, 6012 West William Cannon Drive
Austin, Texas, United States
Apollo Research Institute, 117 Dilworth Plaza
Poth, Texas, United States
Advanced Clinical Research, Inc., 3590 West 9000 South, Suite 230
West Jordan, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007-MUCD-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.